Skip to main content
Figure 4 | BMC Infectious Diseases

Figure 4

From: Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B

Figure 4

Toxicity study of KALSOME™10 in normal mice. Healthy BALB/c mice were treated with 3.5 mg/kg SD and 7.5 mg/kg SD and DDs of KALSOME™10 in 200 μl of 0.02 M PBS through the tail vein. Fourteen days post treatment, liver [SGPT (A), SGOT (B) and Alkaline Phosphatase (C)] and kidney [urea (D) and creatinine (E)] functioning tests were performed on mice serum and compared with that of healthy controls. Data represented as means ± SE for six mice per group and are representative of two independent experiments with similar results.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us